![Charles Baum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Baum
Directeur/Membre du Conseil chez
PMV PHARMACEUTICALS, INC.
Fortune : 14 986 $ au 31/05/2026
Profil
Le Dr Charles M. Baum est président du conseil d'administration d'Oncomyx Therapeutics, Inc. et président, directeur général et administrateur de Mirati Therapeutics, Inc. Il est membre du conseil d'administration de PMV Pharmaceuticals, Inc. et de BCTG Acquisition Corp. et de Mirati Therapeutics, Inc. Le Dr Baum était auparavant employé en tant que directeur indépendant par Immunomedics, Inc. et Array BioPharma, Inc. et Senior VP-Biotherapeutic Clinical Research par Pfizer Inc. Il a obtenu son doctorat à la faculté de médecine de l'université de Washington.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/05/2026 | 9 366 ( 0,02 % ) | 14 986 $ | 31/05/2026 | |
| 04/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Charles Baum
| Sociétés | Poste | Début |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/04/2021 |
| ACRIVON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 22/06/2023 |
Oncomyx Therapeutics, Inc.
 Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and operates software platform to orchestrate an immune response & treat cancer | Président | 06/11/2020 |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Directeur Général | 25/07/2024 |
Crossbow Therapeutics, Inc.
 Crossbow Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops antibodies for cancer treatment | Directeur/Membre du Conseil | - |
Anciens postes connus de Charles Baum
| Sociétés | Poste | Fin |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 08/01/2025 |
| MIRATI THERAPEUTICS | Directeur Général | 23/01/2024 |
| TANGO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2021 |
| IMMUNOMEDICS, INC. | Directeur/Membre du Conseil | 23/10/2020 |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Charles Baum
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PMV Pharmaceuticals, Inc.
 PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Oncomyx Therapeutics, Inc.
Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and operates software platform to orchestrate an immune response & treat cancer | Technology Services |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases | Health Technology |
BCTG Acquisition Corp.
 BCTG Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Health Technology |
Crossbow Therapeutics, Inc.
Crossbow Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops antibodies for cancer treatment | Health Technology |
